Pharmerit India Private Limited, a active foreign private limited company, was established on 21 December 2018 in Mumbai, Maharashtra, India. Engaging in business & it consulting within the professional, scientific and technical sector, it holds CIN: U93090MH2018FTC318679. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Tejas Manharlal Shah (Director), Jennifer Means Stephens (Director), Richard Jones (Additional Director). Past directors included Pratik Yeshwant Kothari, Varun Umesh Ektare, Amrita Mehta. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop-8, Shilpa Trading, Royal Accord, Chakala, Andheri (East) Tarun Bharat Rd,, Mumbai, Maharashtra, 400099.
U93090MH2018FTC318679
318679
21 December 2018
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Pharmerit India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tejas Manharlal Shah | Director | 29 Sep 2024 | Current |
| Jennifer Means Stephens | Director | 21 Dec 2018 | Current |
| Richard Jones | Additional Director | 16 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 12 Jul 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 01 Jun 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pharmerit India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.3% increase. The company also saw a substantial improvement in profitability, with a 70.32% increase in profit. The company's net worth Soared by an impressive increase of 64.27%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pharmerit India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pharmerit India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pharmerit India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmerit India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Richard Jones was appointed as a Additional Director was appointed as a Additional Director on 16 May 2025 & has been associated with this company since 7 months 8 days . was recorded as a recent event.
The activity Pharmerit India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Tejas Manharlal Shah was appointed as a Director was appointed as a Director on 29 Sep 2024 & has been associated with this company since 1 year 2 months . was completed.
Progress on Pharmerit India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on Jennifer Means Stephens was appointed as a Director was appointed as a Director on 21 Dec 2018 & has been associated with this company since 7 years 2 days . was documented.
Progress on Pharmerit India Private Limited was registered on 21 Dec 2018 with Roc Mumbai & aged 7 years 2 days as per MCA records. was documented.
The CIN of Pharmerit India Private Limited is U93090MH2018FTC318679.
Pharmerit India Private Limited is headquartered at Shop-8, Shilpa Trading, Royal Accord, Chakala, Andheri (East) Tarun Bharat Rd,, Mumbai, Maharashtra, 400099.
Pharmerit India Private Limited was incorporated on 21 December 2018.
The current directors of Pharmerit India Private Limited are
The primary industry of Pharmerit India Private Limited is Professional, Scientific And Technical.
Pharmerit India Private Limited is unlisted.
The authorized capital of Pharmerit India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX